公司资料
Windtree Therapeutics 股价、新闻与催化剂
- 股票代码:
- WINT
- 交易所:
- NASDAQ
- 行业:
- MedTech
- 所在地:
- United States
股票表现
0.00 USD (0.00%)
收盘价
最后更新: 2026年8月24日
—
市值
股价为何变动
As of Aug 24, 2026, WINT was little changed and closed at $0.0001. No new same-company headline was identified in the current news window.
公司概览
业务概览
Windtree Therapeutics is a specialty pharmaceutical company focused on respiratory and acute-care therapies, with a history of working on surfactant-based and other hospital-oriented programs. Its business has often been shaped by a narrow pipeline and strategic repositioning.
所在地与行业分类
Windtree is headquartered in the United States and listed on NASDAQ. It sits in specialty pharma and respiratory therapeutics.
商业模式特征
The company depends on clinical progress, corporate strategy, and financing to keep a limited set of programs moving. Investors watch updates on pipeline direction and the company's ability to preserve value in a difficult market.
生物医药行业定位
Windtree occupies a small respiratory-specialty niche within biotech-adjacent pharma. The stock is usually driven by whether the company can create a clear, fundable development thesis.
未来催化剂
- Windtree’s catalysts are respiratory and critical-care product updates, plus any strategic or financing step that supports the company’s next phase. The stock remains sensitive to execution and capital.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。